Help | RSS Feed

Delcath Systems, Inc. (NASD:DCTH) Seasonal Chart

Delcath Systems, Inc. (NASD:DCTH) Seasonality

DCTH Relative to the S&P 500
DCTH Relative to the S&P 500

DCTH Relative to the Sector
DCTH Relative to the Sector

Monthly Seasonal Delcath Systems, Inc. (NASD:DCTH)

Seasonal Chart Analysis

Analysis of the Delcath Systems, Inc. (NASD:DCTH) seasonal charts above shows that a Buy Date of November 16 and a Sell Date of February 18 has resulted in a geometric average return of 20.85% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 61.33% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Delcath Systems Inc is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Its products include Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System.

To download DCTH seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore